$BGMD Company News BG Medicine Inc. falls 10% in
Post# of 145123
Posted On: 03/25/2014 9:55:36 AM
$BGMD Company News
BG Medicine Inc. falls 10% in premarket 8:58 a.m. Jan. 25, 2013 - Steve Gelsi
BG Medicine up 11% in premarket 8:57 a.m. Jan. 3, 2013 - Steve Gelsi
BG Medicine up by 16% in premarket 9:49 a.m. Dec. 14, 2012 - Steve Gelsi
BG Medicine rises 9% in premarket 10:17 a.m. Dec. 12, 2012 - Steve Gelsi
BG Medicine names BioMerieux exec as CEO 10:12 a.m. Jan. 9, 2012 - Steve Gelsi
BG Medicine names Eric Bouvier as CEO 9:38 a.m. Jan. 9, 2012 - Steve Gelsi
IPO scorecard: Pacira, Epocrates up in aftermarket 2:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 2:31 p.m. April 26, 2011 - MarketWatch.com
Insider Buying Is On The Rise In These 4 Rallying Stocks 6:16 p.m. March 20, 2014 - TheStreet.com
Why BG Medicine (BGMD) Hit a One-Year High Today (Update) 4:41 p.m. March 20, 2014 - TheStreet.com
BG Medicine's CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:31 p.m. March 20, 2014 - Seeking Alpha
BG Medicine, Inc. Discusses Q4 2013 Results (Webcast) 8:25 a.m. March 20, 2014 - Seeking Alpha
BG Medicine up big in today's trading 1:51 p.m. March 18, 2014 - Seeking Alpha
BG Medicine meets Nasdaq requirements, shares soar 10:07 a.m. March 12, 2014 - Seeking Alpha
3 Life Science Stocks to Sell Now 3:15 a.m. Feb. 20, 2014 - InvestorPlace.com
3 Life Science Stocks to Sell Now 2:30 p.m. Jan. 30, 2014 - InvestorPlace.com
BG Medicine +24%, says clinical study shows performance of automated VIDAS 3:29 p.m. Jan. 28, 2014 - Seeking Alpha
HWAY and SulAmerica Join Forces, Shares Fall - Analyst Blog 7:30 p.m. Dec. 9, 2013 - Zacks.com
Omnicare Raises Dividend, Approves Share Repurchase - Analyst Blog 4:00 p.m. Dec. 9, 2013 - Zacks.com
Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape 10:25 a.m. Nov. 18, 2013 - Zacks.com
BG Medicine's CEO Discusses Q3 2013 Results - Earnings Call Transcript 12:03 a.m. Nov. 7, 2013 - Seeking Alpha
Healthways Partnership Expands But Stock Down - Analyst Blog 2:50 p.m. Oct. 7, 2013 - Zacks.com
CareFirst Invests in Healthways Partnership - Analyst Blog 2:50 p.m. Oct. 4, 2013 - Zacks.com
NextGxDx and athenahealth Join Forces - Analyst Blog 6:10 p.m. Oct. 1, 2013 - Zacks.com
BG Medicine Says Prelim. Decision by CMS on Galectin-3 National limitation $30.24 7:33 a.m. Sept. 30, 2013 - benzinga.com
BG Medicine - Just Be Patient 4:02 a.m. Aug. 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 4:10 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
BG Medicine's CEO Discusses Q2 2013 Results - Earnings Call Transcript 1:35 p.m. Aug. 8, 2013 - Seeking Alpha
Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure 8:31 a.m. Today - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy 8:15 a.m. March 20, 2014 - GlobeNewswire
BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results 7:50 a.m. March 20, 2014 - GlobeNewswire
Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology 8:25 a.m. March 19, 2014 - PR Newswire - PRF
BG Medicine Announces Fiscal Year 2013 Financial Results Release Date and Conference Call Information 4:48 p.m. March 13, 2014 - GlobeNewswire
BG Medicine Welcomes La Jolla Pharmaceutical Company's Announcement of Positive Top-Line Results of Phase 2 Clinical Trial of Novel Pharmaceutical Compound Targeting Galectin-3 in Chronic Kidney Disease 8:46 a.m. March 12, 2014 - GlobeNewswire
BG Medicine Compliant With NASDAQ Listing Requirements 6:02 p.m. March 11, 2014 - GlobeNewswire
BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers 8:30 a.m. March 10, 2014 - GlobeNewswire
Can This Simple Test Predict Your Chances of Dying? If You Have Coronary Artery Disease, The Answer Is Yes, Say A Group of Renowned Scientists 10:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Heart Failure Study Proves Serial Testing of ST2 Can Help Improve Patient Care And Reduce Cardiovascular Events 9:59 a.m. Feb. 3, 2014 - BusinessWire - BZX
Automated VIDAS(R) Galectin-3 Assay Validated in Published Clinical Research Study 9:31 a.m. Jan. 28, 2014 - GlobeNewswire
BG Medicine to Transfer to the NASDAQ Capital Market; Obtains Requested NASDAQ Extension 9:30 a.m. Jan. 27, 2014 - GlobeNewswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test 9:30 a.m. Dec. 10, 2013 - GlobeNewswire
Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure 9:30 a.m. Nov. 19, 2013 - GlobeNewswire
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer 9:30 a.m. Nov. 14, 2013 - GlobeNewswire
AXAS, POZN, ATRS and BGMD added to NASDAQ Active Stock Watch List at EPR 10:29 a.m. Nov. 6, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Third Quarter Financial Results 8:35 a.m. Nov. 6, 2013 - GlobeNewswire
SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test 8:30 a.m. Nov. 6, 2013 - GlobeNewswire
BG Medicine Inc. falls 10% in premarket 8:58 a.m. Jan. 25, 2013 - Steve Gelsi
BG Medicine up 11% in premarket 8:57 a.m. Jan. 3, 2013 - Steve Gelsi
BG Medicine up by 16% in premarket 9:49 a.m. Dec. 14, 2012 - Steve Gelsi
BG Medicine rises 9% in premarket 10:17 a.m. Dec. 12, 2012 - Steve Gelsi
BG Medicine names BioMerieux exec as CEO 10:12 a.m. Jan. 9, 2012 - Steve Gelsi
BG Medicine names Eric Bouvier as CEO 9:38 a.m. Jan. 9, 2012 - Steve Gelsi
IPO scorecard: Pacira, Epocrates up in aftermarket 2:56 p.m. April 27, 2011 - MarketWatch.com
IPO Scorecard: Update on selected stock offerings 2:31 p.m. April 26, 2011 - MarketWatch.com
Insider Buying Is On The Rise In These 4 Rallying Stocks 6:16 p.m. March 20, 2014 - TheStreet.com
Why BG Medicine (BGMD) Hit a One-Year High Today (Update) 4:41 p.m. March 20, 2014 - TheStreet.com
BG Medicine's CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:31 p.m. March 20, 2014 - Seeking Alpha
BG Medicine, Inc. Discusses Q4 2013 Results (Webcast) 8:25 a.m. March 20, 2014 - Seeking Alpha
BG Medicine up big in today's trading 1:51 p.m. March 18, 2014 - Seeking Alpha
BG Medicine meets Nasdaq requirements, shares soar 10:07 a.m. March 12, 2014 - Seeking Alpha
3 Life Science Stocks to Sell Now 3:15 a.m. Feb. 20, 2014 - InvestorPlace.com
3 Life Science Stocks to Sell Now 2:30 p.m. Jan. 30, 2014 - InvestorPlace.com
BG Medicine +24%, says clinical study shows performance of automated VIDAS 3:29 p.m. Jan. 28, 2014 - Seeking Alpha
HWAY and SulAmerica Join Forces, Shares Fall - Analyst Blog 7:30 p.m. Dec. 9, 2013 - Zacks.com
Omnicare Raises Dividend, Approves Share Repurchase - Analyst Blog 4:00 p.m. Dec. 9, 2013 - Zacks.com
Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape 10:25 a.m. Nov. 18, 2013 - Zacks.com
BG Medicine's CEO Discusses Q3 2013 Results - Earnings Call Transcript 12:03 a.m. Nov. 7, 2013 - Seeking Alpha
Healthways Partnership Expands But Stock Down - Analyst Blog 2:50 p.m. Oct. 7, 2013 - Zacks.com
CareFirst Invests in Healthways Partnership - Analyst Blog 2:50 p.m. Oct. 4, 2013 - Zacks.com
NextGxDx and athenahealth Join Forces - Analyst Blog 6:10 p.m. Oct. 1, 2013 - Zacks.com
BG Medicine Says Prelim. Decision by CMS on Galectin-3 National limitation $30.24 7:33 a.m. Sept. 30, 2013 - benzinga.com
BG Medicine - Just Be Patient 4:02 a.m. Aug. 15, 2013 - Seeking Alpha
10-Q: BG MEDICINE, INC. 4:10 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
BG Medicine's CEO Discusses Q2 2013 Results - Earnings Call Transcript 1:35 p.m. Aug. 8, 2013 - Seeking Alpha
Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure 8:31 a.m. Today - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy 8:15 a.m. March 20, 2014 - GlobeNewswire
BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results 7:50 a.m. March 20, 2014 - GlobeNewswire
Coverage of Top Gainers -- Research on Synta Pharma, BG Medicine, Abraxas Petroleum, and xG Technology 8:25 a.m. March 19, 2014 - PR Newswire - PRF
BG Medicine Announces Fiscal Year 2013 Financial Results Release Date and Conference Call Information 4:48 p.m. March 13, 2014 - GlobeNewswire
BG Medicine Welcomes La Jolla Pharmaceutical Company's Announcement of Positive Top-Line Results of Phase 2 Clinical Trial of Novel Pharmaceutical Compound Targeting Galectin-3 in Chronic Kidney Disease 8:46 a.m. March 12, 2014 - GlobeNewswire
BG Medicine Compliant With NASDAQ Listing Requirements 6:02 p.m. March 11, 2014 - GlobeNewswire
BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers 8:30 a.m. March 10, 2014 - GlobeNewswire
Can This Simple Test Predict Your Chances of Dying? If You Have Coronary Artery Disease, The Answer Is Yes, Say A Group of Renowned Scientists 10:00 a.m. Feb. 5, 2014 - BusinessWire - BZX
Heart Failure Study Proves Serial Testing of ST2 Can Help Improve Patient Care And Reduce Cardiovascular Events 9:59 a.m. Feb. 3, 2014 - BusinessWire - BZX
Automated VIDAS(R) Galectin-3 Assay Validated in Published Clinical Research Study 9:31 a.m. Jan. 28, 2014 - GlobeNewswire
BG Medicine to Transfer to the NASDAQ Capital Market; Obtains Requested NASDAQ Extension 9:30 a.m. Jan. 27, 2014 - GlobeNewswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test 9:30 a.m. Dec. 10, 2013 - GlobeNewswire
Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure 9:30 a.m. Nov. 19, 2013 - GlobeNewswire
BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer 9:30 a.m. Nov. 14, 2013 - GlobeNewswire
AXAS, POZN, ATRS and BGMD added to NASDAQ Active Stock Watch List at EPR 10:29 a.m. Nov. 6, 2013 - ACCESSWIRE
BG Medicine Reports 2013 Third Quarter Financial Results 8:35 a.m. Nov. 6, 2013 - GlobeNewswire
SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test 8:30 a.m. Nov. 6, 2013 - GlobeNewswire
(0)
(0)